|
| ||
|
|
||
C Alone (c + alone)
Selected AbstractsSerological markers of autoimmunity in patients infected with hepatitis C virus: impact of HIV co-infectionHIV MEDICINE, Issue 6 2005OM Adeyemi Objectives: We sought to evaluate the prevalence, predictors and significance of autoantibody expression in patients with chronic hepatitis C (CHC) with or without HIV co-infection. Methods: Retrospective review of laboratory and histologic data for all patients with CHC who had a liver biopsy available. HIV status was documented in all patients. Results analyzed in SPSS10, Chicago, IL, a p value <0.05 was considered significant. Results: 170 patients with hepatitis C viremia, including 107 (63%) HIV co-infection, who had testing for anti-nuclear antibody (ANA) or anti-smooth muscle antibody (ASMA) and anti-mitochondrial antibody (AMA) were included in the study. Overall, 63% (74/117) of patients were ASMA seropositive and 6% (9/153) were positive for ANA. All 117 patients tested for AMA were negative. HIV co-infected patients were significantly more likely to be ASMA positive 71% (53/75) compared to those with hepatitis C alone (50%) [P=0.026]. There were no significant differences in age, gender, race, risk group, alanine aminotransferase (ALT) levels or grade of inflammation on histology between autoantibody positive and negative patients. ASMA positive patients had significantly higher globulin levels (P=0.036) and a trend towards more bridging fibrosis or cirrhosis. Patients with autoantibody expression rarely had histologic features of AIH. Conclusion: We found a high rate of ASMA seropositivity in our cohort of patients with chronic hepatitis C, and HIV co-infection was associated with significantly higher rates of ASMA expression. Autoantibody expression was not associated with demographic or clinical characteristics and does not necessarily preclude antiviral therapy. [source] bcl-2-specific siRNAs restore Gemcitabine sensitivity in human pancreatic cancer cellsJOURNAL OF CELLULAR AND MOLECULAR MEDICINE, Issue 2 2007Kinya Okamoto Abstract Gemcitabine has been shown to ameliorate disease related symptoms and to prolong overall survival in pancreatic cancer.Yet, resistance to Gemcitabine is commonly observed in this tumour entity and has been linked to increased expression of anti-apoptotic bcl-2. We therefore investigated if and to what extend silencing of bcl-2 by specific siRNAs (siBCL2) might enhance Gemcitabine effects in human pancreatic carcinoma cells. siBCL2 was transfected into the pancreatic cancer cell line YAP C alone and 72 hrs before co-incubation with different concentrations of Gemcitabine. Total protein and RNA were extracted for Western-blot analysis and quantitative polymerase chain reaction. Pancreatic cancer xenografts in male nude mice were treated intraperitoneally with siBCL2 alone, Gemcitabine and control siRNA or Gemcitabine and siBCL2 for 21 days. Combination of both methods lead to a synergistic induction of apoptosis at otherwise ineffective concentrations of Gemcitabine. Tumour growth suppression was also potentiated by the combined treatment with siBCL2 and Gemcitabine in vivo and lead to increased TUNEL positivity. In contrast, non-transformed human foreskin fibroblasts showed only minor responses to this treatment. Our results demonstrate that siRNA-mediated silencing of anti-apoptotic bcl-2 enhances chemotherapy sensitivity in human pancreatic cancer cells in vitro and might lead to improved therapy responses in advanced stages of this disease. [source] Intra-arterial chemotherapy with mitomycin C in gallbladder cancer: A follow-up studyJOURNAL OF SURGICAL ONCOLOGY, Issue 2 2005Michaela K. Bode MD Abstract Background and Objectives There is only limited and somewhat controversial information available on hepatic artery infusion of cytotoxic agents in gallbladder cancer. We report the results of 5-year follow-up of all gallbladder cancer patients treated with surgery and intra-arterial mitomycin C or mitomycin C alone in our hospital during 15 years. Methods Thirty-five patients with gallbladder cancer were treated with superselective intra-arterial chemotherapy (SIAC) with mitomycin C during 1981,1996. Survival was measured from diagnosis, and all patients were followed up until death or the end of January 2002. Cumulative survival rates and median survival times were calculated for all patients, according to response to treatment and staging. The data are presented as 5-year survival. Results Median survival times after SIAC for all patients, responders, and non-responders were 48, 60+, and 8.5 months, respectively. Overall response rate was 60%. Survival was significantly better for tumors limited to the gallbladder wall, as expected. Drug toxicity occurred in half of the patients, requiring cessation of chemotherapy in 25% of the cases. Conclusions The median survival of gallbladder cancer patients treated with surgery and SIAC seems to be significantly better compared to the previously reported outcome of surgical treatment alone. Drug toxicity limits the use of i.a. chemotherapy and requires careful monitoring for early side-effects. J. Surg. Oncol. 2005;91:102,106. © 2005 Wiley-Liss, Inc. [source] Dietary vitamin C and E supplementation and reproduction of milkfish Chanos chanos ForsskalAQUACULTURE RESEARCH, Issue 7 2000A C Emata Milkfish Chanos chanos Forsskal broodstock (11 years old, average body weight 5.23,5.73 kg) reared in 10-m-diameter by 3-m-deep floating net cages (31,36 fish per cage) at SEAFDEC AQD's Igang Marine Substation in Guimaras Island, central Philippines, were fed daily at 3% of total body weight formulated diets (36% protein, 7,8% lipid) supplemented with 0.1% vitamin C, 0.05% vitamin E, both vitamin C and E or no vitamin supplementation (control) for 3 years. Reproductive performance was assessed in an attempt to determine the optimum nutrition for successful spawning of milkfish. The total egg production, mean number of eggs per spawning, number of spawns and mean egg diameter were not affected by dietary vitamin C and E supplementation. However, broodstock given dietary supplementation of vitamin C alone or in combination with vitamin E had a higher percentage of spawns with higher (> 90%) percentage egg viability, hatching and cumulative survival rate than those of the control. Broodstock given dietary vitamin E supplementation alone had few spawns, which made the results difficult to analyse. The results confirm the essentiality of vitamin C supplementation in producing more spawns with good egg and larval quality. The production of an adequate volume of good quality eggs and larvae to support hatchery operation is necessary to offset the huge investment in broodstock development, as it takes at least 5 years for milkfish to attain sexual maturation and spawning. [source] | ||||||||||